Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Align Technology, Inc. stock logo
ALGN
Align Technology
$136.00
+0.3%
$134.29
$122.00
$246.19
$9.83B1.71.23 million shs1.03 million shs
DexCom, Inc. stock logo
DXCM
DexCom
$71.06
+0.5%
$72.59
$57.52
$93.25
$27.73B1.474.82 million shs2.86 million shs
HealthEquity, Inc. stock logo
HQY
HealthEquity
$96.34
+0.9%
$92.08
$74.07
$116.65
$8.23B0.47880,437 shs587,646 shs
Henry Schein, Inc. stock logo
HSIC
Henry Schein
$63.59
+0.1%
$66.81
$60.56
$82.49
$7.70B0.811.34 million shs1.56 million shs
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Align Technology, Inc. stock logo
ALGN
Align Technology
+0.31%+4.74%+5.43%-33.84%-34.51%
DexCom, Inc. stock logo
DXCM
DexCom
+0.51%+7.13%+4.19%-20.15%-1.96%
HealthEquity, Inc. stock logo
HQY
HealthEquity
+0.90%+5.82%+2.65%+0.31%+9.96%
Henry Schein, Inc. stock logo
HSIC
Henry Schein
+0.13%+2.51%-8.12%-11.01%-9.44%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Align Technology, Inc. stock logo
ALGN
Align Technology
$136.00
+0.3%
$134.29
$122.00
$246.19
$9.83B1.71.23 million shs1.03 million shs
DexCom, Inc. stock logo
DXCM
DexCom
$71.06
+0.5%
$72.59
$57.52
$93.25
$27.73B1.474.82 million shs2.86 million shs
HealthEquity, Inc. stock logo
HQY
HealthEquity
$96.34
+0.9%
$92.08
$74.07
$116.65
$8.23B0.47880,437 shs587,646 shs
Henry Schein, Inc. stock logo
HSIC
Henry Schein
$63.59
+0.1%
$66.81
$60.56
$82.49
$7.70B0.811.34 million shs1.56 million shs
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Align Technology, Inc. stock logo
ALGN
Align Technology
+0.31%+4.74%+5.43%-33.84%-34.51%
DexCom, Inc. stock logo
DXCM
DexCom
+0.51%+7.13%+4.19%-20.15%-1.96%
HealthEquity, Inc. stock logo
HQY
HealthEquity
+0.90%+5.82%+2.65%+0.31%+9.96%
Henry Schein, Inc. stock logo
HSIC
Henry Schein
+0.13%+2.51%-8.12%-11.01%-9.44%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Align Technology, Inc. stock logo
ALGN
Align Technology
2.41
Hold$181.6733.58% Upside
DexCom, Inc. stock logo
DXCM
DexCom
2.88
Moderate Buy$96.4035.66% Upside
HealthEquity, Inc. stock logo
HQY
HealthEquity
2.93
Moderate Buy$121.3125.92% Upside
Henry Schein, Inc. stock logo
HSIC
Henry Schein
2.38
Hold$76.6720.56% Upside

Current Analyst Ratings Breakdown

Latest ALGN, DXCM, HQY, and HSIC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/23/2025
Align Technology, Inc. stock logo
ALGN
Align Technology
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight$190.00
10/22/2025
Henry Schein, Inc. stock logo
HSIC
Henry Schein
Barrington Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperform$78.00
10/21/2025
DexCom, Inc. stock logo
DXCM
DexCom
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price TargetOverweight$100.00
10/21/2025
Align Technology, Inc. stock logo
ALGN
Align Technology
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetEqual Weight$154.00 ➝ $142.00
10/21/2025
DexCom, Inc. stock logo
DXCM
DexCom
Stifel Nicolaus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$85.00
10/16/2025
Align Technology, Inc. stock logo
ALGN
Align Technology
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetNeutral$160.00 ➝ $155.00
10/15/2025
DexCom, Inc. stock logo
DXCM
DexCom
Truist Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$102.00 ➝ $94.00
10/14/2025
Align Technology, Inc. stock logo
ALGN
Align Technology
Leerink Partners
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOutperform$188.00 ➝ $172.00
10/13/2025
Align Technology, Inc. stock logo
ALGN
Align Technology
Mizuho
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOutperform$210.00 ➝ $170.00
10/10/2025
Align Technology, Inc. stock logo
ALGN
Align Technology
Jefferies Financial Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuyHold$215.00 ➝ $140.00
10/8/2025
HealthEquity, Inc. stock logo
HQY
HealthEquity
KeyCorp
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOverweight$125.00 ➝ $120.00
(Data available from 10/23/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Align Technology, Inc. stock logo
ALGN
Align Technology
$4.00B2.47$9.02 per share15.08$51.60 per share2.64
DexCom, Inc. stock logo
DXCM
DexCom
$4.03B6.91$2.26 per share31.46$5.38 per share13.21
HealthEquity, Inc. stock logo
HQY
HealthEquity
$1.20B6.92$4.30 per share22.40$24.40 per share3.95
Henry Schein, Inc. stock logo
HSIC
Henry Schein
$12.67B0.61$7.34 per share8.66$32.33 per share1.97
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Align Technology, Inc. stock logo
ALGN
Align Technology
$421.36M$5.9322.9315.201.5411.04%13.36%8.32%10/29/2025 (Confirmed)
DexCom, Inc. stock logo
DXCM
DexCom
$576.20M$1.4449.3528.891.4913.29%30.41%10.08%10/30/2025 (Confirmed)
HealthEquity, Inc. stock logo
HQY
HealthEquity
$96.70M$1.6558.3933.921.3711.49%12.04%7.44%12/8/2025 (Estimated)
Henry Schein, Inc. stock logo
HSIC
Henry Schein
$390M$3.1020.5112.672.103.05%14.36%5.52%11/4/2025 (Estimated)

Latest ALGN, DXCM, HQY, and HSIC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/4/2025Q3 2025
Henry Schein, Inc. stock logo
HSIC
Henry Schein
$1.27N/AN/AN/A$3.28 billionN/A
10/30/2025Q3 2025
DexCom, Inc. stock logo
DXCM
DexCom
$0.57N/AN/AN/A$1.18 billionN/A
10/29/2025Q3 2025
Align Technology, Inc. stock logo
ALGN
Align Technology
$2.38N/AN/AN/A$980.75 millionN/A
9/2/2025Q2 2026
HealthEquity, Inc. stock logo
HQY
HealthEquity
$0.92$0.92N/A$0.68$320.68 million$325.80 million
8/5/2025Q2 2025
Henry Schein, Inc. stock logo
HSIC
Henry Schein
$1.19$1.10-$0.09$0.70$3.22 billion$3.24 billion
7/30/2025Q2 2025
Align Technology, Inc. stock logo
ALGN
Align Technology
$2.57$2.49-$0.08$1.72$1.06 billion$1.01 billion
7/30/2025Q2 2025
DexCom, Inc. stock logo
DXCM
DexCom
$0.45$0.48+$0.03$0.45$1.13 billion$1.16 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Align Technology, Inc. stock logo
ALGN
Align Technology
N/AN/AN/AN/AN/A
DexCom, Inc. stock logo
DXCM
DexCom
N/AN/AN/AN/AN/A
HealthEquity, Inc. stock logo
HQY
HealthEquity
N/AN/AN/AN/AN/A
Henry Schein, Inc. stock logo
HSIC
Henry Schein
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Align Technology, Inc. stock logo
ALGN
Align Technology
N/A
1.23
1.10
DexCom, Inc. stock logo
DXCM
DexCom
0.48
1.52
1.35
HealthEquity, Inc. stock logo
HQY
HealthEquity
0.47
4.23
4.23
Henry Schein, Inc. stock logo
HSIC
Henry Schein
0.51
1.41
0.78

Institutional Ownership

CompanyInstitutional Ownership
Align Technology, Inc. stock logo
ALGN
Align Technology
88.43%
DexCom, Inc. stock logo
DXCM
DexCom
97.75%
HealthEquity, Inc. stock logo
HQY
HealthEquity
99.55%
Henry Schein, Inc. stock logo
HSIC
Henry Schein
96.62%

Insider Ownership

CompanyInsider Ownership
Align Technology, Inc. stock logo
ALGN
Align Technology
0.66%
DexCom, Inc. stock logo
DXCM
DexCom
0.32%
HealthEquity, Inc. stock logo
HQY
HealthEquity
1.50%
Henry Schein, Inc. stock logo
HSIC
Henry Schein
1.08%
CompanyEmployeesShares OutstandingFree FloatOptionable
Align Technology, Inc. stock logo
ALGN
Align Technology
20,94572.49 million72.01 millionOptionable
DexCom, Inc. stock logo
DXCM
DexCom
10,300392.15 million390.90 millionOptionable
HealthEquity, Inc. stock logo
HQY
HealthEquity
3,12086.16 million84.86 millionOptionable
Henry Schein, Inc. stock logo
HSIC
Henry Schein
25,000121.27 million119.96 millionOptionable

Recent News About These Companies

Here's How Henry Schein Is Placed Ahead of Q3 Earnings
Henry Schein Q4 EPS Forecast Increased by Zacks Research
Brokers Set Expectations for Henry Schein FY2025 Earnings
Zacks Research Cuts Earnings Estimates for Henry Schein

New MarketBeat Followers Over Time

Media Sentiment Over Time

Align Technology stock logo

Align Technology NASDAQ:ALGN

$136.00 +0.42 (+0.31%)
Closing price 10/23/2025 04:00 PM Eastern
Extended Trading
$136.29 +0.29 (+0.21%)
As of 10/23/2025 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Align Technology, Inc. designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth. The segment also provides Invisalign moderate, lite and express packages, and Invisalign go and Invisalign Go Plus; retention products, Invisalign training, and adjusting tools used by dental professionals during the course of treatment; and Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and orthodontists software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers. This segment also provides Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface designed to enhance dental consultations; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan, as well as subscription software, disposables, rentals, leases, pay per scan, and CAD/CAM software solutions. The company was incorporated in 1997 and is headquartered in Tempe, Arizona.

DexCom stock logo

DexCom NASDAQ:DXCM

$71.06 +0.36 (+0.51%)
Closing price 10/23/2025 04:00 PM Eastern
Extended Trading
$71.00 -0.06 (-0.08%)
As of 10/23/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

HealthEquity stock logo

HealthEquity NASDAQ:HQY

$96.34 +0.86 (+0.90%)
Closing price 10/23/2025 04:00 PM Eastern
Extended Trading
$95.47 -0.87 (-0.90%)
As of 10/23/2025 06:40 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is based in Draper, Utah.

Henry Schein stock logo

Henry Schein NASDAQ:HSIC

$63.59 +0.08 (+0.13%)
Closing price 10/23/2025 04:00 PM Eastern
Extended Trading
$63.60 +0.01 (+0.02%)
As of 10/23/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Henry Schein, Inc. provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products, such as branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners; and value-added practice solutions comprising practice consultancy, education, revenue cycle management and financial services, e-services, practice technology, and network and hardware services, as well as consulting, and continuing education services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.